On this page:Overview Publications Researchers Institutions Open access

PICO Portalanswers from OpenAlex

Bon Secours Mercy Health

InstitutionResearch output, impact & collaborations

Bon Secours Mercy Health is a institution indexed in PICO Portal from OpenAlex.

What is known about Bon Secours Mercy Health?

PICO Portalrecord summary

Bon Secours Mercy Health is a research organisation in Cincinnati, US. OpenAlex records 452 works and 11,189 citations for it. 233 researchers list it as their most recent affiliation.

How many works does Bon Secours Mercy Health have?

PICO Portalindexed works

Bon Secours Mercy Health has 452 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Bon Secours Mercy Health →

How many citations does Bon Secours Mercy Health have?

PICO Portalcitation count

Bon Secours Mercy Health has 11,189 citations in the OpenAlex counts PICO Portal stores.

See the listed works for Bon Secours Mercy Health →

How many researchers are at Bon Secours Mercy Health?

PICO Portalresearcher count

Bon Secours Mercy Health has 233 researchers in the PICO Portal index.

See the researchers listed on this page →

What is the average h-index at Bon Secours Mercy Health?

PICO Portalavg h-index

Bon Secours Mercy Health has an average h-index of 98 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Bon Secours Mercy Health?

PICO Portalror

The ROR for Bon Secours Mercy Health is on the source record.

Open the ROR →

What is the OpenAlex record for Bon Secours Mercy Health?

PICO Portalopenalex

The OpenAlex for Bon Secours Mercy Health is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Bon Secours Mercy Health?

PICO Portaltop researchers by citations

Mitchell L. Shiffman · Hepatitis C virus research

400 works54,370 citations

What are the most-cited papers on Bon Secours Mercy Health?

PICO Portalmost cited works

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Frederik Nevens, Pietro Andreoné, G. Mazzella, Simone I. Strasser, Christopher L. Bowlus, Pietro Invernizzi, Joost P.H. Drenth, Paul J. Pockros, Jarosław Reguła, Ulrich Beuers, Michael Trauner, David Jones, Annarosa Floreani, Simon Hohenester, Velimir A. Luketic, Mitchell L. Shiffman, Karel J. van Erpecum, Vı́ctor Vargas, Catherine Vincent, Gideon M. Hirschfield, Hemant Shah, Bettina E. Hansen, Keith D. Lindor, Hanns–Ulrich Marschall, Kris V. Kowdley, Roya Hooshmand-Rad, Tonya Marmon, Shawn Sheeron, Richard Pencek, Leigh MacConell, Mark Pruzanski, Д. А. Шапиро

New England Journal of Medicine. 20161,120 CitationsOPEN ACCESS

Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study

David Jones, Pol Boudes, Mark G. Swain, Christopher L. Bowlus, Michael Galambos, Bruce R. Bacon, Yvonne Döerffel, Norman Gitlin, Stuart C. Gordon, Joseph A. Odin, David Sheridan, M A Wörns, Virginia Clark, Linsey Corless, Heinz Hartmann, Mark Jonas, Andreas E. Kremer, George Mells, Peter Buggisch, B. Freilich, Cynthia Levy, John M. Vierling, David Bernstein, Marek Hartleb, Ewa Janczewska, Fedja A. Rochling, Hemant Shah, Mitchell L. Shiffman, John H. Smith, Yun‐Jung Choi, Alexandra Steinberg, Mónika Varga, Harinder Chera, Robert L. Martin, Charles A. McWherter, Gideon M. Hirschfield

The Lancet. Gastroenterology & hepatology. 2017187 Citations

How much of the research on Bon Secours Mercy Health is open access?

PICO Portalopen access share

50%OPEN ACCESS

Gold

Green

Hybrid

Bronze

50%

Closed

50%